10 notable regulatory approvals of diagnostic devices over the past 30 days

Along with radiology-specific software and products, this list may include newly greenlit offerings for use in radiotherapeutic, histologic, endoscopic, laparoscopic and other settings that are increasingly important to multidisciplinary care.

FEops (Gent, Belgium): FDA clearance for imaging-based preoperative planning of left atrial appendage occlusion (April 4)

Radiaction Medical (Tel Aviv): FDA clearance for C-arm mountable scattered radiation shielding (April 4)

Paige (New York): CE-IVD and UKCA marks for AI detection of breast cancer metastases in lymph notes on histopathology slides (April 6)

Merit Medical (South Jordan, Utah): FDA clearance for biopsy-deployable wire-free breast localization reflector (April 11)

Mauna Kea (Paris & Boston): FDA clearance for molecular flourescence image guidance during endoscopic, laparoscopic and needle-based procedures (April 12)

3D Systems (Rock Hill, S.C.): FDA clearance for 3D-printed radiotherapy bolus (April 21)

Clarius (Vancouver, B.C.): Health Canada approval of smartphone-compatible handheld ultrasound scanners (April 21)

Lunit (Seoul): CE mark for AI tumor proportion score analyzer (April 27)

Samsung/Boston Imaging (Seoul/Boston): FDA clearance for portable digital radiography machine (April 28)

iSono Health (South San Francisco): FDA clearance for automated wearable 3D breast ultrasound (May 3)

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

The patient, who was being cared for in the ICU, was not accompanied or monitored by nursing staff during his exam, despite being sedated.

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.